California State Teachers Retirement System (CalSTRS)’s Insight Molecular Diagnostics IMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,297
Closed -$39K 3254
2022
Q1
$39K Sell
1,297
-433
-25% -$13.8K ﹤0.01% 3089
2021
Q4
$75K Buy
1,730
+104
+6% +$5.98K ﹤0.01% 3077
2021
Q3
$116K Sell
1,626
-3,268
-67% -$300K ﹤0.01% 2952
2021
Q2
$562K Sell
4,894
-481
-9% -$47K ﹤0.01% 2584
2021
Q1
$558K Buy
5,375
+615
+13% +$58.4K ﹤0.01% 2477
2020
Q4
$228K Hold
4,760
﹤0.01% 2785
2020
Q3
$132K Buy
4,760
+1,499
+46% +$43K ﹤0.01% 2906
2020
Q2
$125K Buy
3,261
+1,587
+95% +$82K ﹤0.01% 2904
2020
Q1
$82K Buy
1,674
+19
+1% +$931 ﹤0.01% 2851
2019
Q4
$74K Hold
1,655
﹤0.01% 2958
2019
Q3
$69K Hold
1,655
﹤0.01% 2967
2019
Q2
$82K Buy
+1,655
New +$138K ﹤0.01% 2991
2018
Q2
Sell
-320
Closed -$13K 3047
2018
Q1
$13K Hold
320
﹤0.01% 2972
2017
Q4
$30K Hold
320
﹤0.01% 2966
2017
Q3
$48K Hold
320
﹤0.01% 2981
2017
Q2
$33K Buy
+320
New +$36.4K ﹤0.01% 3007
2016
Q2
Sell
-300
Closed -$28K 3028
2016
Q1
$28K Buy
+300
New +$26.6K ﹤0.01% 2964

Other funds holding IMDX

California State Teachers Retirement System (CalSTRS)'s IMDX Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of Insight Molecular Diagnostics (IMDX) in Q2 2022, closing a stake of 1,297 shares — an estimated $39K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in IMDX in Q1 2016 and held it in 17 quarters. The position peaked at $562K in Q2 2021. 75 funds tracked by Wall St. Rank hold IMDX as of Q2 2022.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Insight Molecular Diagnostics position as of Q2 2022 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 1,297 Insight Molecular Diagnostics shares in Q2 2022, an estimated $39K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Insight Molecular Diagnostics in Q1 2016 and held it in 17 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Insight Molecular Diagnostics position peaked at $562K in Q2 2021.
  • 75 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.